Three cases of autoinflammatory disease with novel NLRC4 mutations, and the first mutation reported in the CARD domain of NLRC4 associated with autoinflammatory infantile enterocolitis (AIFEC)

• Published in: Pediatric rheumatology online journal Vol. 22; no. 1; pp. 90 - 7
• Main Authors: Asna Ashari, Kosar, Parvaneh, Nima, Mirnia, Kayvan, Ayati, Mehri, Saeedi, Maryam, Salehzadeh, Farhad, Shahrooei, Mohammad, Sangsari, Razieh, Rohani, Pejman, Ziaee, Vahid
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 18.10.2024; BMC
• Subjects: Adalimumab; Adolescent; AIFEC; Autoinflammatory infantile enterocolitis; Calcium-Binding Proteins - genetics; CARD Signaling Adaptor Proteins - genetics; Diarrhea; Diseases; Enterocolitis; Enterocolitis - genetics; Familial cold autoinflammatory syndrome; FCAS4; Female; Fever; Gain of Function Mutation; Genetic aspects; Hereditary Autoinflammatory Diseases - diagnosis; Hereditary Autoinflammatory Diseases - genetics; Humans; Hydrops fetalis; Hyperthermia; Infant; Macrophages; Male; Mutation; NLRC4; NLRC4-macrophage associated syndrome; Seizures (Medicine); Zoledronic acid; Familial cold autoinflammatory syndrome; NLRC4-macrophage associated syndrome; AIFEC; NLRC4; FCAS4; Autoinflammatory infantile enterocolitis; NLRC4-MAS
• ISSN: 1546-0096; 1546-0096
• DOI: 10.1186/s12969-024-01020-z

Gain of function (GOF) mutations in NOD-like receptor family CARD-containing 4 protein (NLRC4) gene induce a wide spectrum of autoinflammatory phenotypes. Currently, we categorize them into four groups: familial cold autoinflammatory syndrome (FCAS)4, autoinflammatory infantile enterocolitis (AIFEC), NLRC4-macrophage associated syndrome (MAS), and neonatal-onset multisystem inflammatory disease (NOMID). The rarity and complexity of the disease necessitate the description of new cases and a reexamination of our understanding of the condition. We present three patients with NLRC4-GOF mutations and AIFEC phenotypes. The first patient is an infant girl with periodic fever, seizure, high inflammatory markers, and an episode of macrophage associated syndrome (MAS). History of recurrent fever episodes since childhood was reported in mother and maternal grandmother. A heterozygous mutation was found in CARD domain of NLRC4: c.A91C: p.Asn31His. The second patient is an adolescent boy with periodic fever, diarrhea, aphthous stomatitis, seizure, and central nervous system (CNS) vasculitis. A heterozygous mutation was found in NLRC4 gene: c.1202T > C. p. Val401Ala. The third patient is a child with chronic diarrhea and elevated inflammatory markers. We found a heterozygous mutation in NLRC4 gene: c.390delG: p.S132Afs*21. All mutations have been reported for the first time as NLRC4 mutations associated with autoinflammation. We introduced novel mutations in the CARD domain and between CARD and NBD domain in the first and third cases, respectively. All three children are under remission following treatment. NLRC4-GOF mutations can be associated with autoinflammation with diverse symptoms. Given the rarity of the disease and the possibility of new mutations being identified, the existence of a phenotype/genotype correlation has yet to be thoroughly investigated. The variety in manifestations and severity spectrum mandates a variety of treatments. Adalimumab has shown favorable outcomes in our AIFEC cases.